期刊文献+

RNA干扰下调RhoA表达对卵巢癌细胞SKOV-3恶性表型的影响 被引量:4

Influence of RNAi-induced RhoA gene silencing on malignant behaviors of ovarian carcinoma cells
原文传递
导出
摘要 目的:探讨RNA干扰(RNAi)下调RhoA表达对卵巢癌细胞SKOV-3恶性表型的影响。方法:构建RhoA基因特异性短发夹状RNA(shRNA)真核表达载体,以脂质体介导转染卵巢癌细胞SKOV-3,RT-PCR和蛋白质印迹法检测RNAi后SKOV-3中RhoA的mRNA及蛋白表达水平变化;Boyden小室体外侵袭和划痕实验观察细胞侵袭和迁移能力,MTT比色法测定转染前后细胞增殖及粘附能力的变化。结果:转染RhoA shRNA的实验组细胞与转染空载体的对照组细胞比较,RhoA mRNA的表达分别为(5.46±2.02)%和(56.37±17.42)%,蛋白质的表达分别为(6.03±2.04)%和(59.03±19.94)%,细胞平均侵袭百分比为(15.84±4.17)%和(33.64±4.64)%,愈合百分比为(44.79±6.21)%和(68.36±4.46)%,增殖能力(A值)分别为0.726±0.166和1.703±0.340,P<0.05(n=3);而粘附能力(A值)分别为0.833±0.137和0.894±0.189,P>0.05(n=3)。结论:通过RNAi降低RhoA的表达能降低卵巢癌细胞SKOV-3体外侵袭、迁移和增殖能力。 OBJECTIVE:To investigate the effects of RhoA gene silencing induced by RNA interference (RNAi) on SKOV-3 cell malignant behaviors in vitro. METHODS:The vector containing shRNA targeting RhoA gene was constructed and transfected into human ovarian carcinoma cell line SKOV-3. The expressions of mRNA and protein in SKOV-3 were detected respectively by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. Boyden chamber in vitro invasion assay and wound-healing assay were used to evaluate the invasive and migratory capability of SKOV-3. The changes in the adhesion and proliferation of the cells were detected by MTT assay. RESULTS:The group transfected with RhoA shRNA was compared with the control group. The expression of RhoA mRNA was (5.46±2.02)% and (56.37±17.42)%. The protein level was (6.03±2.04)% and (59.03±19.94)%. The cell invasion percentage was (15.84±4.17)% and (33.64±4.64)%. The percent wound closure was (44.79±6.21)% and (68.36±4.46)%. The absorbance value of proliferation was 0.726±0.166 and 1.703±0.340(P0.05,n=3),and the value of adhesion was 0.833±0.137 and 0.894±0.189 (P0.05,n=3). CONCLUSION:RNAi-induced RhoA gene silencing may decrease the capacity of SKOV-3 invasion,migration and proliferation in vitro.
出处 《中华肿瘤防治杂志》 CAS 2010年第17期1321-1324,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家重点基础研究发展规划973项目(2009CB521800)
关键词 RNA干扰 RHO因子 卵巢肿瘤 表型 RNA interference Rho factor ovarian neoplasms phenotype
  • 相关文献

参考文献9

  • 1Zhao L, Xu G, Zhou J, et al. The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro [J]. Oneol Rep, 2006, 15(5):1147-1152.
  • 2赵良平,王薇娜,张庆华,田训,黄磊,梁逢奇,熊国平,马丁.RhoA在卵巢癌细胞SKOV3体外侵袭和迁移过程中的作用[J].现代妇产科进展,2008,17(5):321-324. 被引量:3
  • 3白爱民,贾艳敏,张晓菁.siRNA为基础的RNAi在肿瘤基因治疗中的应用进展[J].中华肿瘤防治杂志,2007,14(12):953-955. 被引量:16
  • 4Fukata M, Nakagawa M, Kaibuchi K. Roles of Rho family GT -Pases in cell polarisation and directional migralion[J] . Curr Opin Cell Biol, 2003,15(5) :590- 597.
  • 5O'Connor K L, Mercurio A M. Protein kinase A regulates Rac and is required for the growth factor stimulated migration of carcinoma cells[J]. J BiolChem. 2001, 276(51):47895-47900.
  • 6O'Connor K L, Nguyen B K, Mercurio A M. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrinand cAMPmetabolism[J]. J Cell Biol, 2000, 148(2): 253-258.
  • 7Liberto M,Cobrinik D, Minden A. Rho regulates p21 (CIP1), cyclin D1, and checkpoint control in mammary epithelial cells [J]. Oncogene, 2002, 21(10):1590-1599.
  • 8Vidal A, Millard S S, Miller J P, et al. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status[J]. J Biol Chem,2002, 277(19) :16433-16440.
  • 9Fukata M, Kaibuchi K. Rho family GTPases in cadherin-mediated cell cell adhession[J]. Nat Rev MolCellBiol, 2001, 2(12): 887-897.

二级参考文献23

  • 1Zhang L,Yang N,Mohamed-Hadley A,et al.Vector-based RNAi,a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J].Biochem Biophys Res Commun,2003,303(4):1169-1178.
  • 2Hannon G J.RNA interference[J].Nature,2002,418(6894):244-51.
  • 3Czauderna F,Fechtner M,Dames S,et al.Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells[J].Nucleic Acids Res,2003,31(11):2705-2716.
  • 4Chae S S,Paik J H,Furneaux H,et al.Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference[J].J Clin Invest,2004,114 (8):1082-1089.
  • 5Minakuchi Y,Takeshita F,Kosaka N,et al.Atelocollagen-mediated synt hetic small interfering RNA delivery for effective gene silencing in vit ro and in vivo[J].Nucleic Acids Res,2004,32(13):109.
  • 6Gondi C S,Lakka S S,Dinh D H,et al.RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion,angiogenesis and tumor growth in gliomas[J].Oncogene,2004,23(52):8486-8496.
  • 7Taulli R,Accornero P,Follenzi A,et al.RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis[J].Cancer Gene Ther,2005,12(5):456-463.
  • 8Sumimoto H,Yamagata S,Shimizu A,et al.Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference[J].Gene Ther,2005,12(1):95-100.
  • 9Uchida H,Tanaka T,Sasaki K,et,al.Adenovirus-mediated tra-nsfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo[J].Mol Ther,2004,10(1):162-171.
  • 10Yang G,Thompson J A,Fang B,et al.Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer[J].Oncogene,2003,22(36):5694-5701.

共引文献17

同被引文献32

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部